Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000126977 | SCV000170508 | benign | not specified | 2014-02-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000226159 | SCV000285805 | likely benign | Aortic aneurysm, familial thoracic 4 | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000126977 | SCV000306214 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000226159 | SCV000744027 | likely benign | Aortic aneurysm, familial thoracic 4 | 2017-03-31 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000226159 | SCV000745487 | likely benign | Aortic aneurysm, familial thoracic 4 | 2015-12-15 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000126977 | SCV000919818 | benign | not specified | 2018-09-04 | criteria provided, single submitter | clinical testing | Variant summary: MYH11 c.654+10T>C alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.0004 in 276970 control chromosomes in the gnomAD database, including 1 homozygote. The observed variant frequency is approximately 321-fold above the estimated maximal expected allele frequency for a pathogenic variant in MYH11 causing Aortopathy phenotype (1.3e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.654+10T>C in individuals affected with Aortopathy and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV001170346 | SCV001332919 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2018-03-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001812094 | SCV002049034 | likely benign | not provided | 2022-03-01 | criteria provided, single submitter | clinical testing |